News

All of our latest updates

Press releases

News

November 4, 2024

Lokon Pharma Announces Collaboration to Combine its TME Gene Engineering Product with Anti-PD-1 Antibody Tislelizumab in Pancreatic Cancer

Results from first pancreatic cancer trial using immunostimulatory gene therapy is published in Lancet Oncology

January 12, 2022

Lokon Pharma Initiates a Collaboration with Affibody to Develop Novel Cancer Therapeutics

August 28, 2020

Lokon Pharma Expands Collaboration with Roche Evaluating LOAd703 Immunostimulatory Gene Cancer Therapy in Combination with Tecentriq® (atezolizumab) into Colorectal Cancer

Lokon Pharma Announces Collaboration to Combine LOAd703 Oncolytic Virotherapy with Checkpoint Blockade in Pancreatic Cancer and Melanoma

January 19, 2017

First Patient Treated by a Novel Oncolytic Virus Armed with Immune Stimulators

November 2, 2021

Lokon will present our work at the Gastrointestinal Cancer Drug Development Summit.

October 26, 2021

Lokon will present our work at the 6th annual Oncolytic Virotherapy Summit.

September 29, 2021

Lokon will present a poster at the AACR pancreatic cancer virtual meeting.

Media

Malou efter 10

Bengt fick aggressiv cancer - hade ett år kvar att leva

Barncancerfonden

Immunterapi på 100 sekunder

Malou efter 10

Forskarna om cancervaccinet: ”Behövs pengar”

Uppsala universitet

Immunterapi är ett nytt sätt att bekämpa cancer.

Forskarpodden

Virus som dödar cancer